AXA1957
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for AXA1957, covering 2021-07-02 to 2021-09-23. Get the full timeline:
Most recent: Clinical Trial Update: Study of the Safety and Tolerability of AXA1957 in Adolescent Subjects With Non-Alcoholic Fatty Liver Disease (NAFLD) [NA]